Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

RXST stock hub

RxSight, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RXSTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

242.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RXST

In the news

Latest news · RXST

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-17.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-93.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RXST market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001111485
Company name	RxSight, Inc.
Country	United States
Country code	US
Cusip	78349D107
Employees	461
Employees Change	-37%
Employees Change Percent	-7.43
Enterprise value	$35.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2021-07-30
Isin	US78349D1072
Last refreshed	2026-05-10
Market cap	$242.2M
Market cap category	Micro-Cap
Price	$5.85
Price currency	USD
Rev Per Employee	276,522.78x
Sector	Healthcare
Sic	3851
Symbol	RXST
Website	https://rxsight.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.26%
EV Sales Forward	0.26x
EV/Sales	0.28x
FCF yield	-8.91%
P/B ratio	0.91x
P/S ratio	1.9x
PS Forward	1.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-43.42%
EBITDA Margin	-40.81%
Gross margin	77.02%
Gross Profit	$98.2M
Gross Profit Growth	-7.89%
Gross Profit Growth Q	-17.05%
Gross Profit Growth3 Y	52.04%
Gross Profit Growth5 Y	104.49%
Net Income	$-46.6M
Net Income Growth Years	0%
Pretax Margin	-36.54%
Profit Margin	-36.59%
Profit Per Employee	$-101,167
ROA	-11.21
Roa5y	-16.63
ROCE	-20.01
ROE	-17.06
Roe5y	-56.71
ROIC	-93.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-60.76%
Cagr3y	-31.68%
EPS Growth Years	0
Revenue Growth	-14.05x
Revenue Growth Q	-18.48x
Revenue Growth Years	0x
Revenue Growth3 Y	30.35x
Revenue Growth5 Y	52.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.41
Assets	$304M
Cash	$217.9M
Current Assets	$279.2M
Current Liabilities	$27.4M
Debt	$10.8M
Debt Equity	$0.04
Equity	$267.3M
Interest Coverage	-3,459.1
Liabilities	$36.7M
Long Term Assets	$24.8M
Long Term Liabilities	$9.3M
Net Cash	$207.1M
Net Cash By Market Cap	$85.5
Net Cash Growth	-4.71%
Net Debt Equity	$-0.77
Tangible Book Value	$267.3M
Tangible Book Value Per Share	$6.46
WACC	10.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.2
Inventory Turnover	1
Net Working Capital	$35.5M
Quick ratio	8.78
Working Capital	$251.8M
Working Capital Turnover	$0.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.18%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-60.74%
200-day SMA	8.76
3Y total return	-68.12%
50-day SMA	7.06
50-day SMA vs 200-day SMA	50under200
All Time High	66.54
All Time High Change	-91.21%
All Time High Date	2024-05-07
All Time Low	5.3
All Time Low Change	10.38%
All Time Low Date	2026-05-07
ATR	0.46
Beta	1.23
Beta1y	1.48
Beta2y	1.37
Ch YTD	-43.86
High	5.87
High52	16.74
High52 Date	2025-05-20
High52ch	-65.05%
Low	5.63
Low52	5.3
Low52 Date	2026-05-07
Low52ch	10.38%
Ma50ch	-17.08%
Premarket Change Percent	1.72
Premarket Price	$5.9
Premarket Volume	653
Price vs 200-day SMA	-33.19%
RSI	33.46
RSI Monthly	32.72
RSI Weekly	33.98
Sharpe ratio	-0.88x
Sortino ratio	-1.06
Total Return	-3.18%
Tr YTD	-43.86
Tr1m	-13.46%
Tr1w	-20.95%
Tr3m	-30.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	29,739,504x
Earnings Revenue Estimate Growth	-21.52x
Operating Income	$-55.3M
Operating margin	-43.42
Price target	$9.44
Price Target Change	$61.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,047,134%
Float Percent	89.49%
Net Borrowing	-20,000
Shares Insiders	5.36%
Shares Institutions	83.67%
Shares Out	41,396,609
Shares Qo Q	0.32%
Shares Yo Y	3.18%
Short Float	15.05%
Short Ratio	7.37
Short Shares	13.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-54M
Average Volume	742,132.25x
Bv Per Share	6.46
CAPEX	$-4M
Ch1m	-13.46
Ch1w	-20.95
Ch1y	-60.74
Ch3m	-30.27
Ch3y	-68.12
Ch6m	-37.57
Change	0.86%
Change From Open	0.86
Close	5.8
Days Gap	0
Depreciation Amortization	3,324,000
Dollar Volume	5,401,539
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-55.3M
EBITDA	$-52M
EPS	$-1.14
F Score	2
FCF	$-21.6M
FCF EV Yield	-61.46x
FCF Per Share	$-0.52
Financing CF	2,262,000
Fiscal Year End	December
Founded	1,997
Income Tax	$54,000
Investing CF	4,882,000
Ipr	-63.44
Iprfo	-66.57
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	8.8
Ma150ch	-33.55%
Ma20	7.09
Ma20ch	-17.44%
Net CF	-10,427,000
Next Earnings Date	2026-08-06
Open	5.8
Optionable	Yes
Position In Range	91.67
Post Close	5.85
Postmarket Change Percent	-0.51
Postmarket Price	$5.82
Ppne	22,992,000
Pre Close	5.8
Price Date	2026-05-08
Ptbv Ratio	0.91
Relative Volume	1.24x
Revenue	127,477,000x
SBC By Revenue	25.43x
Share Based Comp	32,417,000
Tax By Revenue	0.04x
Tr6m	-37.57%
Us State	California
Volume	923,340
Z Score	4.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RXST pay a dividend?

Capital-return profile for this ticker.

Performance

RXST stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RXST?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.7%

Float: +89.5% of shares outstanding

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RXST momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.5

Neutral momentum band

Price vs 200-day MA

-33.2%

50/200-day relationship not available

Beta (5Y)

1.23

More volatile than the market

Sharpe ratio

-0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RXST

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RXST stock rating?

RxSight, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RXST analysis?

The full report lives at /stocks/RXST/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RXST?

The latest report frames RXST around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RXST page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.